This site is intended for healthcare professionals only
LoginRegister
GSK Blujepa bags USFDA nod for treatment of uUTIs in female adults, paediatric patients 12 years of age and olderCDSCO Panel grants GSK's Protocol Amendment Proposal To Study Belantamab mafodotin
USFDA concludes inspection at Zydus Lifesciences SEZ II, Ahmedabad plantUSFDA issues EIR for Zydus Lifesciences Pharmez transdermal patch manufacturing facility
Mankind Pharma bags CDSCO nod to start Phase 1 trials of Autoimmune drug candidateMankind Pharma transfers OTC business to subsidiary Mankind Consumer Products
Sun Pharma Halol facility gets OAI status from USFDASun Pharma gets exclusive worldwide rights to commercialize Philogen anti-cancer immunotherapy...
Darzalex receives positive EMA Committee opinion for high-risk smouldering multiple myeloma: Janssen-Cilag InternationalApex Consumer Court slaps Rs 35 lakh compensation on Johnson & Johnson for faulty hip replacement...
Zydus Lifesciences Reports Rs 6,573.7 Cr Revenue in Q1 FY26, Net Profit Rises 3%Zydus, CSIR-CDRI Lucknow to develop drug for Chronic Kidney Disease induced Osteoporosis
Biocon Opens First US Manufacturing Facility in New Jersey, Invests USD 30 Million in ExpansionBiocon gets 4 USFDA observations for Bengaluru facility
PfizerPfizer gets CDSCO Panel nod to study antimicrobial FDC Avibactam plus Aztreonam
CDSCO Launches One-Year Online Dual Use NOC System for Bulk Drug ImportsIRGMA Welcomes CDSCO's New Guidelines, Urges to stop import of substandard gloves
Aurobindo Pharma in lead to acquire Zentiva for US 5.5 billion: ET ReportAurobindo Pharma arm Telangana facility gets 10 USFDA observations
Biocon Opens First US Manufacturing Facility in New Jersey, Invests USD 30 Million in ExpansionUSFDA concludes inspection at Biocon Biologics Malaysia Insulins facility
USFDA concludes audit at Cohance Lifesciences Jaggaiahpet facilityUSFDA issues EIR for Piramal Pharma Ahmedabad facility
X